Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CN Bio
CN Bio
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Marketing
CN Bio appoints Joseph Parisi as US Director of Sales
CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Joseph Parisi as US Director of Sales
Research & Development
CN Bio wins "Most Impactful Industry Collaboration of the Year" at the OBN Awards
Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry
Research & Development
CN Bio opens new laboratory facilities to extend OOC contract research services capabilities
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for organ-on-a-chip research services
Research & Development
CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit
Despite research efforts to combat the growing prevalence of NASH, to-date, there are no approved therapeutics
Research & Development
CN Bio and iiCON announce COVID-19 research collaboration
The £174m programme aims to bring together industry, academia, and clinicians to accelerate the discovery, development and deployment of treatments and products
Manufacturing
CN Bio launches oncology service for drug discovery
The service provides a means to explore the relationships between pharmacokinetics, pharmacodynamics (PK/PD) and efficacy in vitro
Research & Development
CN Bio licenses gut modelling tool from MIT
The GuMi device was licensed by Professor Linda Griffith at MIT's Department of Biological Engineering and joint patent-holder, Professor Rebecca Carrier at Northeastern University
Subscribe now